The Mayo Clinic’s telestroke network allows connected spoke facilities around-the-clock access to remote consults with Mayo neurologists. An analysis of costs and outcomes from a modeled seven-spoke telestroke network compared with those from traditional, community hospital-based treatment revealed a telestroke network may increase the use of clot-busting drugs, catheter-based interventional procedures and other stroke therapies, and allow more patients to be discharged back home.
“This study shows that a hub-and-spoke telestroke network is not only cost-effective from the societal perspective, but it’s cost-saving,” said lead study author Bart Demaerschalk, MD, director of the Mayo Clinic Telestroke Program, in a news release.
The study also found telestroke services resulted in a patient’s gain of 0.02 quality-adjusted life-years over a lifetime, suggesting the benefits of telestroke to patients and society extends beyond cost-savings. “The results serve to inform government organizations, insurers, healthcare institutions, practitioners, patients and the general public that an upfront investment in telemedicine and stroke network personnel can be justified in our health systems,” Dr. Demaerschalk said.
More Articles on Telehealth:
7M Patients Will Use Telehealth by 2018
Up Your ICU Management Game with a Tele-ICU Program
UVA to Use Telemedicine to Diagnose Stroke Patients Before They Reach the Hospital
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
